Currently Enrolling for a Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Research Study

Pregnant women 18 years and older  in Forney and Houston, Texas are encouraged to join FNAIT research study

I'm Interested

Eligible participants must:


Be female, 18 years of age or older

picture of a folder with a medical cross on the outside

Be 10-14 weeks pregnant at time of screening

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare immune disorder. FNAIT occurs when the baby’s platelets are attacked and destroyed by the mother’s immune cells in her blood stream.  It is estimated that FNAIT can occur every 1 in 1,000 live births. This immune response can develop when the mother’s blood is exposed to her baby’s blood, either during development of the fetus in the womb or when the baby is being born. FNAIT can occur in a woman’s first pregnancy and/or in subsequent pregnancies.

Pediatrician vaccinating little baby on light background

The purpose of this research trial is to collect data on the frequency of women at higher FNAIT risk among pregnant women of different racial and ethnic characteristics.

*This study may provide compensation for your time and travel.

I'm Interested